1. Gen Y, Muramatsu T, Inoue J, Inazawa J. miR-766-5p targets super-enhancers by downregulating CBP and BRD4. Cancer Res. 2021 Aug 5. doi:10.1158/0008-5472.CAN-21-0649.
2. Liu C, Gen Y, Tanimoto K, Muramatsu T, Inoue J, Inazawa J. Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells. Mol Ther Nucleic Acids. 2021 May 11;25:83-92. doi: 10.1016/j.omtn.2021. 05.001. eCollection 2021 Sep 3.
3. Inoue J*, Kishikawa M*, Tsuda H, Nakajima Y, Asakage T, Inazawa J. Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma. Cancer Science. 2021 May 8. doi:10.1111/cas.14938. Online ahead of print. *equally contributed
4. Kishikawa M, Inoue J, Hamamoto H, Kobayashi K, Asakage T, Inazawa J. Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer. Biochemistry and Biophysics Reports. 2021 May 9. 26:101009. doi:10.1016/j.bbrep.2021.101009. eCollection 2021 Jul.
5. Nishino K, Yoshimatsu Y, Muramatsu T, Sekimoto Y, Mitani K, Kobayashi E, Okamoto S, Ebana H, Okada Y, Kurihara M, Suzuki K, Inazawa J, Takahashi K, Watabe T, Seyama K. Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis. Sci Rep. 2021 Apr 16. 11:8406. doi: 10.1038/s41598-021-88064-3.
6. Uehara DT, Mitsubuchi H, Inazawa J: A missense variant in NUF2, a component of the kinetochore NDC80 complex, causes impaired chromosome segregation and aneuploidy associated with microcephaly and short stature. Hum Genet. 2021 Mar 15. doi:10.1007/s00439-021-02273-4.
7. Beck DB, Basar MA, Anthony J, Asmar AJ, Thompson JJ, Oda H, Uehara DT, Saida K, Pajusalu S, Talvik I, D'Souza P, Bodurtha J, Mu W, Barañano KW, Miyake N, Wang R, Kempers M, Tamada T, Nishimura Y, Okada S, Kosho T, Dale R, Mitra A, Macnamara E, Undiagnosed Diseases Network, Matsumoto N, Inazawa J, Walkiewicz M, Õunap K, Tifft CJ, Aksentijevich I, Kastner DL, Rocha PP, Werner A: Linkage-specific deubiquitylation by OTUD5 defines an embryonic pathway intolerant to genomic variation. Science Advances. 2021 Jan 20. 7:eabe2116. doi:10.1126/sciadv.abe2116.
